logo

For the Inventor, By the Inventor

Grand Prairie, TX, United States of America

Neos Therapeutics, LP


USPTO Granted Patents = 13


Trademarks = 5

Forward Citations = 214

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Mark Tengler (13 out of 14 patents)

silverMedal Russell McMahen (11 out of 12 patents)

bronzeMedal Daniel Lockhart (5 out of 5 patents)

4.  Michael Sloane (3 out of 4 patents)

5.  Paul Taskey (2 out of 2 patents)

6.  Nathan Teuscher (1 out of 1 patent)

7.  Russ McMahen (1 out of 1 patent)

8.  Yashwant Vishnupant Pathak (1 out of 1 patent)


13 patents:

1. 11166947 - Effective dosing of a child for the treatment of ADHD with methylphenidate (2021-11-09),
2. 9839619 - Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particles (2017-12-12),
3. 9522120 - Compositions and methods of making sustained release liquid formulations (2016-12-20),
4. 9265737 - Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles (2016-02-23),
5. 9089496 - Compositions comprising methylphenidate complexed with ion-exchange resin particles (2015-07-28),
6. 9072680 - Compositions comprising methylphenidate complexed with ion-exchange resin particles (2015-07-07),
7. 9057675 - Methods of formulating and designing liquid drug suspensions containing ion exchange resin particles (2015-06-16),
8. 9017731 - Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles (2015-04-28),
9. 8840924 - Compositions and methods of making rapidly dissolving ionically masked formulations (2014-09-23),
10. 8512759 - Methods of formulating and designing liquid drug suspensions containing ion exchange resin particles (2013-08-20),
11. 8470375 - Method of formulating and designing liquid drug suspensions containing ion exchange resin particles (2013-06-25),
12. 8318210 - Compositions and methods of making sustained release liquid formulations (2012-11-27),
13. 8313770 - Modifying drug release in suspensions of ionic resin systems (2012-11-20),
Company Overview
Neos Therapeutics, LP is a biopharmaceutical company based in Grand Prairie, Texas, specializing in the development and commercialization of innovative drug delivery systems. The company focuses on addressing the needs of patients with central nervous system disorders, particularly attention deficit hyperactivity disorder (ADHD). Neos Therapeutics leverages advanced formulation technologies to create products that enhance therapeutic efficacy and patient adherence, aiming to improve the quality of life for individuals affected by these conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#10 in Grand Prairie, TX

#1,487 in Texas

#23,838 in US

#45,039 in the World

Grand Prairie, TX (US)
Grand Prairie, TX, United States of America

Neos Therapeutics, LP

Forward Citations = 214

8 inventors:

goldMedal Mark Tengler (13 out of 14 patents)

silverMedal Russell McMahen (11 out of 12 patents)

bronzeMedal Daniel Lockhart (5 out of 5 patents)

4.  Michael Sloane (3 out of 4 patents)

5.  Paul Taskey (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neos Therapeutics, LP. Retrieved from https://idiyas.com/company/neos-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…